144 related articles for article (PubMed ID: 9209689)
1. Implication of CYP 3A in the toxicity of cyclosporin G (CsG), cyclosporin A (CsA) and FK506 on rat hepatocytes in primary culture.
Ellouk-Achard S; Martin C; Pham-Huy C; Duc HT; Thevenin M; Dutertre-Catella H; Warnet JM; Claude JR
Arch Toxicol; 1997; 71(7):437-42. PubMed ID: 9209689
[TBL] [Abstract][Full Text] [Related]
2. FK506 (Tacrolimus) decreases the cytotoxicity of cyclosporin A in rat hepatocytes in primary culture: implication of CYP3A induction.
Ellouk-Achard S; Martin C; Duc HT; Dutertre-Catella H; Thevenin M; Warnet JM; Claude JR
Arch Toxicol; 1998 Apr; 72(5):257-63. PubMed ID: 9630010
[TBL] [Abstract][Full Text] [Related]
3. Modulation of energy status and cytotoxicity induced by FK506 and cyclosporin A in a renal epithelial cell line.
Massicot F; Martin C; Dutertre-Catella H; Ellouk-Achard S; Pham-Huy C; Thevenin M; Rucay P; Warnet JM; Claude JR
Arch Toxicol; 1997; 71(8):529-31. PubMed ID: 9248632
[TBL] [Abstract][Full Text] [Related]
4. Experimental nephrotoxicity, hepatotoxicity and pharmacokinetics of cyclosporin G versus cyclosporin A.
Burdmann EA; Andoh TF; Rosen S; Lindsley J; Munar MY; Elzinga LW; Bennett WM
Kidney Int; 1994 Mar; 45(3):684-91. PubMed ID: 8196271
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporine A and FK506 induce osteoclast apoptosis in mouse bone marrow cell cultures.
Igarashi K; Hirotani H; Woo JT; Stern PH
Bone; 2004 Jul; 35(1):47-56. PubMed ID: 15207740
[TBL] [Abstract][Full Text] [Related]
6. In vivo effects of cyclosporin A and ketoconazole on the pharmacokinetics of representative substrates for P-glycoprotein and cytochrome P450 (CYP) 3A in rats.
Kageyama M; Namiki H; Fukushima H; Ito Y; Shibata N; Takada K
Biol Pharm Bull; 2005 Feb; 28(2):316-22. PubMed ID: 15684491
[TBL] [Abstract][Full Text] [Related]
7. Use of human organ slices to evaluate the biotransformation and drug-induced side-effects of pharmaceuticals.
Vickers AE
Cell Biol Toxicol; 1994 Dec; 10(5-6):407-14. PubMed ID: 7697504
[TBL] [Abstract][Full Text] [Related]
8. Troglitazone increases cytochrome P-450 3A protein and activity in primary cultures of human hepatocytes.
Ramachandran V; Kostrubsky VE; Komoroski BJ; Zhang S; Dorko K; Esplen JE; Strom SC; Venkataramanan R
Drug Metab Dispos; 1999 Oct; 27(10):1194-9. PubMed ID: 10497147
[TBL] [Abstract][Full Text] [Related]
9. Characterization of rat cytochrome P450 isozymes involved in the covalent binding of cyclosporin A to microsomal proteins.
Sadrieh N; Thomas PE
Toxicol Appl Pharmacol; 1994 Aug; 127(2):222-32. PubMed ID: 8048065
[TBL] [Abstract][Full Text] [Related]
10. Primary porcine enterocyte and hepatocyte cultures to study drug oxidation reactions.
Bader A; Hansen T; Kirchner G; Allmeling C; Haverich A; Borlak JT
Br J Pharmacol; 2000 Jan; 129(2):331-42. PubMed ID: 10694240
[TBL] [Abstract][Full Text] [Related]
11. Molecular and pharmacokinetic evaluation of rat hepatic and gastrointestinal cytochrome p450 induction by tamoxifen.
Cotreau MM; von Moltke LL; Harmatz JS; Greenblatt DJ
Pharmacology; 2001; 63(4):210-9. PubMed ID: 11729359
[TBL] [Abstract][Full Text] [Related]
12. Cyclosporin A-induced free radical generation is not mediated by cytochrome P-450.
Krauskopf A; Buetler TM; Nguyen NS; Macé K; Ruegg UT
Br J Pharmacol; 2002 Feb; 135(4):977-86. PubMed ID: 11861326
[TBL] [Abstract][Full Text] [Related]
13. Metabolism-dependent stimulation of reactive oxygen species and DNA synthesis by cyclosporin A in rat smooth muscle cells.
Nguyen NS; Cottet-Maire F; Buetler TM; Lo Russo A; Krauskopf AS; Armstrong JM; Vickers AE; Macé K; Rüegg UT
Free Radic Biol Med; 1999 Dec; 27(11-12):1267-75. PubMed ID: 10641720
[TBL] [Abstract][Full Text] [Related]
14. Cyclosporine A and tacrolimus: in vitro investigations on the differential interactions with the cytochrome P450 system in rat and human liver.
Lupp A; Kuhn UD; Herwig R; Karge E; Rost M; Scheele J; Fleck C
Exp Toxicol Pathol; 2003 Jun; 54(5-6):467-73. PubMed ID: 12877359
[TBL] [Abstract][Full Text] [Related]
15. Different effects of cyclosporine a and FK506 on potassium transport systems in MDCK cells.
Aker S; Heering P; Kinne-Saffran E; Deppe C; Grabensee B; Kinne RK
Exp Nephrol; 2001; 9(5):332-40. PubMed ID: 11549851
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of cyclosporin A, cyclosporin G, and the novel cyclosporin derivative IMM 125 in isolated glomeruli and cultured rat mesangial cells: a morphometric analysis.
Potier M; Wolf A; Cambar J
Nephrol Dial Transplant; 1998 Jun; 13(6):1406-11. PubMed ID: 9641169
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome P450-generated reactive metabolites cause mitochondrial permeability transition, caspase activation, and apoptosis in rat hepatocytes.
Haouzi D; Lekéhal M; Moreau A; Moulis C; Feldmann G; Robin MA; Lettéron P; Fau D; Pessayre D
Hepatology; 2000 Aug; 32(2):303-11. PubMed ID: 10915737
[TBL] [Abstract][Full Text] [Related]
18. Negative regulation by dexamethasone of fluvastatin-inducible CYP2B expression in primary cultures of rat hepatocytes: role of CYP3A.
Kocarek TA; Reddy AB
Biochem Pharmacol; 1998 May; 55(9):1435-43. PubMed ID: 10076536
[TBL] [Abstract][Full Text] [Related]
19. Effects of phenobarbital on metabolism and toxicity of diclofenac sodium in rat hepatocytes in vitro.
Wang AG; Xia T; Yuan J; Yu RA; Yang KD; Chen XM; Qu W; Waalkes MP
Food Chem Toxicol; 2004 Oct; 42(10):1647-53. PubMed ID: 15304311
[TBL] [Abstract][Full Text] [Related]
20. In vitro investigations on the differential pro-oxidant and/or antioxidant properties of cyclosporin A and tacrolimus in human and rat liver microsomes.
Lupp A; Kuhn UD; Karge E; Adam G; Fleck C
Int J Clin Pharmacol Ther; 2006 May; 44(5):225-32. PubMed ID: 16724577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
